DK2131845T3 - 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former - Google Patents

5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former

Info

Publication number
DK2131845T3
DK2131845T3 DK08717228.4T DK08717228T DK2131845T3 DK 2131845 T3 DK2131845 T3 DK 2131845T3 DK 08717228 T DK08717228 T DK 08717228T DK 2131845 T3 DK2131845 T3 DK 2131845T3
Authority
DK
Denmark
Prior art keywords
phenyl
polymorphs
morpholin
isoxazole
ylmethyl
Prior art date
Application number
DK08717228.4T
Other languages
Danish (da)
English (en)
Inventor
Martin James Drysdale
Brian William Dymock
Christoph Krell
Michael Mutz
Holger Petersen
Weijia Zheng
Original Assignee
Novartis Ag
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38134307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2131845(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Vernalis R&D Ltd filed Critical Novartis Ag
Application granted granted Critical
Publication of DK2131845T3 publication Critical patent/DK2131845T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK08717228.4T 2007-03-01 2008-02-28 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former DK2131845T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103346 2007-03-01
PCT/EP2008/052443 WO2008104595A1 (en) 2007-03-01 2008-02-28 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

Publications (1)

Publication Number Publication Date
DK2131845T3 true DK2131845T3 (da) 2012-07-16

Family

ID=38134307

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08717228.4T DK2131845T3 (da) 2007-03-01 2008-02-28 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former

Country Status (40)

Country Link
US (3) US8163747B2 (enExample)
EP (2) EP2545921A3 (enExample)
JP (1) JP2010520176A (enExample)
KR (1) KR20090122218A (enExample)
CN (2) CN101636162A (enExample)
AR (1) AR065519A1 (enExample)
AT (1) ATE552836T1 (enExample)
AU (1) AU2008220800B2 (enExample)
BR (1) BRPI0807992A2 (enExample)
CA (1) CA2678043A1 (enExample)
CL (1) CL2008000618A1 (enExample)
CO (1) CO6210828A2 (enExample)
CR (1) CR10989A (enExample)
CY (1) CY1113805T1 (enExample)
DK (1) DK2131845T3 (enExample)
DO (1) DOP2009000209A (enExample)
EA (1) EA017075B1 (enExample)
EC (1) ECSP099602A (enExample)
ES (1) ES2384906T3 (enExample)
GE (1) GEP20115309B (enExample)
GT (1) GT200900236A (enExample)
HR (1) HRP20120535T1 (enExample)
IL (1) IL200401A0 (enExample)
MA (1) MA31204B1 (enExample)
MX (1) MX2009009233A (enExample)
NI (1) NI200900161A (enExample)
NZ (1) NZ578854A (enExample)
PA (1) PA8771101A1 (enExample)
PE (1) PE20090166A1 (enExample)
PL (1) PL2131845T3 (enExample)
PT (1) PT2131845E (enExample)
RS (1) RS52351B (enExample)
SI (1) SI2131845T1 (enExample)
SM (1) SMAP200900080A (enExample)
TN (1) TN2009000357A1 (enExample)
TW (1) TW200844102A (enExample)
UA (1) UA101950C2 (enExample)
UY (1) UY30943A1 (enExample)
WO (1) WO2008104595A1 (enExample)
ZA (1) ZA200905417B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
TWI450898B (zh) * 2008-07-04 2014-09-01 Sigma Tau Res Switzerland Sa 具有抗腫瘤活性之芳基異唑化合物
WO2010060854A1 (en) 2008-11-25 2010-06-03 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
BR112012017994B8 (pt) * 2010-01-21 2020-12-08 Aprea Ab composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
JP2013519727A (ja) * 2010-02-17 2013-05-30 イルドン ファーム シーオー.,エルティーディー. 新規の5員複素環誘導体及びその製造方法
KR20120031854A (ko) 2010-09-27 2012-04-04 한국전자통신연구원 시간 및 주파수 특징을 이용하는 음악 음원 분리 장치 및 방법
WO2013015661A2 (en) * 2011-07-28 2013-01-31 Ildong Pharm Co.,Ltd. Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101166749B1 (ko) * 2003-02-11 2012-07-27 베르날리스(캠브리지)리미티드 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
US20060070405A1 (en) * 2004-10-06 2006-04-06 Anheuser-Busch, Inc. Method for the production of amber glass with reduced sulfur-containing emissions
CA2677651A1 (en) 2007-02-15 2008-08-21 Novartis Ag Combinations of therapeutic agents for treating cancer
WO2010069458A1 (de) 2008-12-17 2010-06-24 Merck Patent Gmbh Hexahalochromat(lll)-komplexe

Also Published As

Publication number Publication date
SI2131845T1 (sl) 2013-02-28
BRPI0807992A2 (pt) 2014-06-17
DOP2009000209A (es) 2009-09-15
WO2008104595A1 (en) 2008-09-04
UA101950C2 (ru) 2013-05-27
GEP20115309B (en) 2011-10-25
PE20090166A1 (es) 2009-03-14
TN2009000357A1 (en) 2010-12-31
ZA200905417B (en) 2010-05-26
NI200900161A (es) 2010-07-27
CR10989A (es) 2010-03-01
ATE552836T1 (de) 2012-04-15
CL2008000618A1 (es) 2008-09-12
AU2008220800A1 (en) 2008-09-04
CN101636162A (zh) 2010-01-27
EP2545921A3 (en) 2013-04-10
MA31204B1 (fr) 2010-02-01
MX2009009233A (es) 2010-06-02
EP2545921A2 (en) 2013-01-16
RS52351B (sr) 2012-12-31
KR20090122218A (ko) 2009-11-26
CY1113805T1 (el) 2016-07-27
ECSP099602A (es) 2009-12-28
US20120172592A1 (en) 2012-07-05
PA8771101A1 (es) 2009-02-09
US8487095B2 (en) 2013-07-16
EA017075B1 (ru) 2012-09-28
CN102302500A (zh) 2012-01-04
NZ578854A (en) 2012-03-30
ES2384906T3 (es) 2012-07-13
CO6210828A2 (es) 2010-10-20
EP2131845B1 (en) 2012-04-11
GT200900236A (es) 2011-09-14
US20130296556A1 (en) 2013-11-07
US20100093732A1 (en) 2010-04-15
SMAP200900080A (it) 2010-01-19
UY30943A1 (es) 2008-10-31
AR065519A1 (es) 2009-06-10
PT2131845E (pt) 2012-07-10
EP2131845A1 (en) 2009-12-16
EA200901141A1 (ru) 2010-04-30
TW200844102A (en) 2008-11-16
HK1139073A1 (en) 2010-09-10
AU2008220800B2 (en) 2012-02-16
JP2010520176A (ja) 2010-06-10
IL200401A0 (en) 2010-04-29
PL2131845T3 (pl) 2012-09-28
CA2678043A1 (en) 2008-09-04
US8163747B2 (en) 2012-04-24
HRP20120535T1 (hr) 2012-07-31

Similar Documents

Publication Publication Date Title
DK2131845T3 (da) 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former
HUS2300029I1 (hu) Fungicid vegyületek és keverékek
RU2465270C3 (ru) Полиморфная форма 4-[3-(4-циклопропанкарбонилпиперазин-1-карбонил)-4-фторбензил]-2н-фталазин-1-она
IL192102A0 (en) 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors
DE602006016303D1 (de) 3,4-dihydro-2H-benzoÄ1,4Üoxazin- und 3,4-dihydro-2H-benzoÄ1,4Üthiazin-VERBINDUNGEN ALS ALPHA2C-ADRENOREZEPTOR-ANTAGONISTEN
DE502005007430D1 (de) Akkuschrauber
DE502005005415D1 (de) Akkuschrauber
DK3473101T3 (da) Isoxazolinsammensætninger og deres anvendelse som antiparasitik for feliner
MA28994B1 (fr) Composition immunogene
HUE042847T2 (hu) A 44 xiloglukanáz család egyik variánsát tartalmazó felületaktív készítmény
LT3034497T (lt) 3,5-diamino-6-chlor-n-(n-(4-(4-(2-(heksil(2,3,4,5,6-penta-hidroksiheksil)amino)etoksi)fenil)butil)karbamimidoil)pirazin-2-karboksamidas
EP1558804A4 (en) Garment steamer
DK1910336T3 (da) 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluormethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamid-monohydrochloridsalt-monohydrat
DE502007001893D1 (de) Handgeführtes Eintreibgerät
DK2527714T3 (da) Modificeret latexfriktionsformindsker
ATE509906T1 (de) Mandelsäurehydrazide
IL202073A0 (en) Substituted oxazolidinones and the use thereof
EP2001815A4 (en) CEMENTIC MATERIAL
DK2053921T3 (da) Ny antifungal sammensætning
ATE395077T1 (de) Hundeimpfstoffe gegen bordetella bronchiseptica
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
EP2176651A4 (en) ELECTROCHEMICAL TEST STRIPS
DE502007001111D1 (de) Handgeführtes Eintreibgerät
EP2382224A4 (en) METALLHYDRAZIDMATERIALIEN
DK1954668T3 (da) Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer